UNSPSC 51241261: Podophyllotoxin

This classification denotes a colchicine-site binding agent with the molecular formula C22H22O8, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier L36H50F353, chemically known as furo(3,4:6,7)naphtho(2,3-d)-1,3-dioxol-6(5ah)-one, 5,8,8a,9-tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)- but more generally known as podofilox, which bears U.S. NIH Compound Identifier 4865. European Medicines Agency schedules Podofilox in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14925MIG.

World Health Organization schedules podofilox in its Anatomical Therapeutic Chemical (ATC) Classification and its WHO-DD or Drug Dictionary.

UNSPSC 51241261 Podophyllotoxin is a Commodity code that does not reflect the scope of work actually being solicited under it in recent state and local procurement activity. The single identified opportunity under this code—the City of Tampa Fire Rescue Department's ITB 25-P-00157 for Medical Aid Supplies—requests a broad range of first aid and emergency medical consumables including antiseptic sprays, hydrogen peroxide, aspirin, pain relievers, bandages, first aid kits, and emergency blankets, with annual quantities ranging from 1 to 2,700 units per item. Podophyllotoxin, a plant-derived cytotoxic agent used in specialized pharmaceutical applications, bears no relationship to the general emergency medical supplies being procured. The code shows minimal relevant recent activity; state and local procurement offices do not appear to be buying podophyllotoxin as a standalone commodity.

The City of Tampa Fire Rescue Department issued the only recent solicitation tagged to this code, with a due date of April 9, 2025, and a total departmental budget of $100,000 for the one-year award period with two optional one-year renewals. The procurement includes set-aside provisions for City-certified Small Local Business Enterprises and Underutilized Woman and Minority Owned Business Enterprises, offering bid discounts up to $10,000 for SLBEs and $20,000 for U-WMBEs. Vendors must provide business licenses, minority business status documentation, and conflict of interest disclosures, with all medications required to carry a minimum nine-month expiration date from acceptance. The mismatch between the code's nominal pharmaceutical scope and Tampa's broad medical-supplies solicitation suggests either a cataloging error in the source data or that podophyllotoxin is not a category state and local procurement offices are actively buying.